BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 26699290)

  • 1. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy.
    Dhanesar SK; Lim TY; Du W; Bruno TL; Frank SJ; Kudchadker RJ
    J Appl Clin Med Phys; 2015 Sep; 16(5):62–75. PubMed ID: 26699290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
    Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
    Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
    Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
    Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
    Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J
    Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
    Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.
    Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
    Med Phys; 2013 Mar; 40(3):031717. PubMed ID: 23464312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
    Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
    Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a phantom to validate high-dose-rate brachytherapy treatment planning systems with heterogeneous algorithms.
    Moura ES; Micka JA; Hammer CG; Culberson WS; DeWerd LA; Rostelato ME; Zeituni CA
    Med Phys; 2015 Apr; 42(4):1566-74. PubMed ID: 25832047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DVH-Based Inverse Planning Using Monte Carlo Dosimetry for LDR Prostate Brachytherapy.
    Mountris KA; Visvikis D; Bert J
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):503-510. PubMed ID: 30315873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
    Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
    Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addendum to brachytherapy dose-volume histogram commissioning with multiple planning systems.
    Gossman MS
    J Appl Clin Med Phys; 2016 May; 17(3):502-505. PubMed ID: 27167288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approach of ultra-focal brachytherapy for low- and intermediate-risk prostate cancer with custom-linked I-125 seeds: A feasibility study of optimal dose coverage.
    Brun T; Bachaud JM; Graff-Cailleaud P; Malavaud B; Portalez D; Popotte C; Aziza R; Lusque A; Filleron T; Ken S
    Brachytherapy; 2018; 17(3):544-555. PubMed ID: 29525514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brachytherapy dose-volume histogram commissioning with multiple planning systems.
    Gossman MS; Hancock SS; Kudchadker RJ; Lundahl PR; Cao M; Melhus CS
    J Appl Clin Med Phys; 2014 Mar; 15(2):4620. PubMed ID: 24710449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of dosimetric effects of metallic artifact reduction and tissue assignment on Monte Carlo dose calculations for
    Assam I; Vijande J; Ballester F; Pérez-Calatayud J; Poppe B; Siebert FA
    Med Phys; 2022 Sep; 49(9):6195-6208. PubMed ID: 35925023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
    Bannon EA; Yang Y; Rivard MJ
    Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
    Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
    J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric and radiobiological investigation of permanent implant prostate brachytherapy based on Monte Carlo calculations.
    Haidari AM; Miksys N; Soubiran P; Cygler JE; Holmes O; Perry G; Thomson RM
    Brachytherapy; 2019; 18(6):875-882. PubMed ID: 31400953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry modeling for focal high-dose-rate prostate brachytherapy.
    Mason J; Al-Qaisieh B; Bownes P; Thwaites D; Henry A
    Brachytherapy; 2014; 13(6):611-7. PubMed ID: 25085456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapy.
    Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
    Brachytherapy; 2014; 13(6):603-10. PubMed ID: 24913435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.